FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Back

1995S-0316
RPT 356
Volume 279

Cover page, Letter from CFSAN to Iwade Research Institute of Mycology Co., Ltd.

75-Day Notification for New Dietary Ingredient ABM-FD

References

Tab 1 - Manufacturing Information - Redacted

Tab 2 - ABM-FD: Toxicity Study by Oral Gavage Administration to CD Rats for 13 weeks. Huntington Life Sciences, part 2, part 3, part 4, part 5, part 6

Tab 3 - ABM-FD (EXTRACT OF HIMEMATSUTAKE): Bacterial Reverse Mutation Test. Huntingdon Life Sciences

Tab 4 - ABM-FD (EXTRACT OF HIMEMATSUTAKE): In Vitro Mutation Test Using Mouse Lymphoma L5178Y Cells. Huntingdon Life Sciences

Tab 5 - ABM-FD (EXTRACT OF HIMEMATSUTAKE): Rat Micronucleus Test. Huntingdon Life Sciences

Tab 6 - The Safety of Extended Consumption of Freeze-Dry of Agaricus blazei Murrill (Iwade strain 101) Himenatsutake Extracts. Osami Kajimoto, Yutaka Ikeda, Mitsuharu Tabune, Akane Sakamoto, Yoshitaka Kajimoto Published Material

Tab 7 - Lack of a subchronic toxicity of an aqueous extract of Agaricus blazei Murrill in F344 rats. Y. Kuroiwa, et al.: Food and Chemical Toxicology 43, 1047-1053, 2005. Published Material

Top | Back

Page last updated November 20, 2006 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management